Related Experiment Video
Updated: Mar 1, 2026

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
Published on: May 7, 2015
Diet quality of children post-liver transplantation does not differ from healthy children
Abeer S Alzaben1, Krista MacDonald1, Cheri Robert2
1Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, AB, Canada.
Insights
Children after liver transplant (LTX) and healthy children have poor dietary quality (DQ). This highlights risks for obesity and metabolic issues, especially for transplant patients on immunosuppressants.
Area of Science:
- Pediatric Nutrition
- Transplant Medicine
- Dietary Assessment
Background:
- Limited research exists on the dietary habits of children post-liver transplant (LTX).
- Understanding dietary intake and quality is crucial for managing health outcomes in pediatric transplant recipients.
- Children on immunosuppressive therapies may face unique nutritional challenges.
Purpose of the Study:
- To assess and compare the dietary intake and dietary quality (DQ) of healthy children and children post-LTX.
- To identify potential nutritional differences that could impact growth and metabolic health.
Main Methods:
- A comparative study involving children and adolescents (2-18 years) post-LTX (n=27) and healthy controls (n=28).
- Data collection included anthropometric measurements and two 24-hour dietary recalls (weekday and weekend).
- Dietary intake of added sugars, high-fructose corn syrup (HFCS), fructose, glycemic index (GI), and glycemic load (GL) were calculated. Dietary quality was assessed using the Healthy Eating Index for Children (HEI-C), Diet Quality Index-Children Adaptation (DGI-CA), and Diet Quality Index-International (DQI-I).
Main Results:
- Children post-LTX exhibited lower height-for-age z-scores compared to healthy children, though weight-for-age z-scores were similar.
- No significant differences were found in energy, macronutrient, added sugar, HFCS, fructose, GI, GL, or most micronutrient intakes between the groups.
- Dietary quality scores (HEI-C, DGI-CA, DQI-I) and the majority of specific nutrient intakes were comparable between children post-LTX and healthy children, with both groups demonstrating poor dietary quality (>40% had low DQ scores).
Conclusions:
- Both healthy children and children post-LTX consume diets of poor quality, indicating a need for nutritional interventions.
- Poor dietary quality in this population may increase the risk of obesity and metabolic dysregulation, particularly for transplant recipients on immunosuppressive therapies.
- Further research and targeted dietary guidance are warranted for pediatric liver transplant recipients to optimize nutritional status and long-term health outcomes.
Abstract:
Little has been studied regarding the diets of children following LTX. The study aim was to assess and compare dietary intake and DQ of healthy children and children post-LTX. Children and adolescents (2-18 years) post-LTX (n=27) and healthy children (n=28) were studied. Anthropometric and demographic data and two 24-hour recalls (one weekend; one weekday) were collected. Intake of added sugar, HFCS, fructose, GI, and GL was calculated. DQ was measured using three validated DQ indices: the HEI-C, the DGI-CA, and the DQI-I. Although no differences in weight-for-age z-scores were observed between groups, children post-LTX had lower height-for-age z-scores than healthy children (P<.01). With the exception of vitamin B12, no significant differences in energy and macronutrient (protein, carbohydrate, and fat), added sugar, HFCS, fructose, GI, GL, and micronutrient intakes and DQ indices (HEI-C, DGI-CA, and DQI-I) between groups were observed (P>.05). The majority of children in both groups (>40%) had low DQ scores. No significant interrelationships between dietary intake, anthropometric, and demographic were found (P>.05). Both healthy and children post-LTX consume diets with poor DQ. This has implications for risk of obesity and metabolic dysregulation, particularly in transplant populations on immunosuppressive therapies.
Related Concept Videos
Kidney Transplant I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Kidney Transplant III: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Kidney Transplant II: Surgical Procedure

